TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

CITIGROUP INC's Holding History (CIK: 0000831001)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 50,000 Value ($000) $71 Avg Close Range
Q3 2025
Shares 50,000 Value ($000) $56 Avg Close Range
Q2 2025
Shares 50,000 Value ($000) $48 Avg Close Range
Q1 2024
Shares 20,000,000 Value ($000) $12,696 Avg Close Range
Q4 2023
Shares 20,022,000 Value ($000) $13,114 Avg Close Range
Q3 2023
Shares 20,022,000 Value ($000) $12,890 Avg Close Range
Q2 2023
Shares 15,022,000 Value ($000) $12,008 Avg Close Range
Q1 2023
Shares 15,022,000 Value ($000) $14,692 Avg Close Range
Q4 2022
Shares 15,000,000 Value ($000) $13,650 Avg Close Range
Q3 2022
Shares 15,000,000 Value ($000) $15,263 Avg Close Range
Q2 2022
Shares 15,000,000 Value ($000) $14,970 Avg Close Range
Q1 2022
Shares 15,000,000 Value ($000) $15,893 Avg Close Range